Not that I remember during the meeting.... When we had the meeting just to discuss what we would do and so on, we gave the chair the procedure that we have for all our reports: when we deal with a committee or an individual, we will present the methodology, what will be the approach, and then there's an agreement that we will follow it. At the end of that, if there is some follow-up to do, or additional information, we will be happy to do it. The World Health Organization was discussed in the context of follow-up eventually.
If I may, Mr. Chair, I want to come back to one thing.
You mentioned the 25%. Yes, it is prudent. It is a balance. I can tell you, for example, that the Quebec government already negotiated something else with its own suppliers, which is much higher than that. It is not yet in force in Quebec, but they reached an agreement of almost a 38% reduction on generics. You can see that with the purchasing power, if it's there at the national level, certainly you can go way beyond the 25%.
Thank you.